TheraPsil is a non-profit organization dedicated to advancing education, research, and legal reform related to psychedelic-assisted psychotherapy. We provide independent training programs for healthcare professionals who wish to better understand the therapeutic potential, ethical considerations, and current legal frameworks surrounding psilocybin and MDMA in Canada.
While TheraPsil does not supply controlled substances or assist individuals in obtaining them, we support prescribers and patients by offering educational resources about the legal and regulatory context—including how to responsibly navigate processes like clinical trials or regulatory exemptions where appropriate.
Our Fundamentals Training Programs and Prescriber Training help prepare licensed professionals to deliver high-quality, evidence-informed care in a changing legal and clinical landscape.
In addition to training and education, TheraPsil also advocates for policy change and has supported legal challenges when we believe Canadians’ rights under the Charter of Rights and Freedoms may be unjustly restricted.
